For research use only. Not for therapeutic Use.
FAUC-213(CAT: I012645) is a potent and selective antagonist of the β2-adrenergic receptor (β2-AR), widely used in pharmacological and cardiovascular research. By specifically blocking β2-AR signaling, it helps elucidate the receptor’s role in smooth muscle relaxation, metabolic regulation, and cardiovascular function. FAUC-213 is valuable for studying conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular disorders, where β2-AR plays a significant role. Its high selectivity and consistent bioactivity make it ideal for in vitro and in vivo studies, advancing the understanding of β2-adrenergic signaling pathways and the development of targeted therapeutics.
Catalog Number | I012645 |
CAS Number | 337972-47-1 |
Synonyms | 2-[4-(4-Chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine |
Molecular Formula | C18H19ClN4 |
Purity | ≥95% |
Target | Neuronal Signaling |
IUPAC Name | 2-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]pyrazolo[1,5-a]pyridine |
InChI | InChI=1S/C18H19ClN4/c19-15-4-6-17(7-5-15)22-11-9-21(10-12-22)14-16-13-18-3-1-2-8-23(18)20-16/h1-8,13H,9-12,14H2 |
InChIKey | DTRXURJDKOYCCD-UHFFFAOYSA-N |
SMILES | C1CN(CCN1CC2=NN3C=CC=CC3=C2)C4=CC=C(C=C4)Cl |